Business ❯Pharmaceutical Industry ❯Vaccine Development
Moderna's Combined Vaccine Revenue Challenges
The Trump administration cites oversight concerns and broader scrutiny of mRNA vaccine spending in its review of the deal awarded during Biden's tenure.
